AU2947795A - Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability - Google Patents

Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability

Info

Publication number
AU2947795A
AU2947795A AU29477/95A AU2947795A AU2947795A AU 2947795 A AU2947795 A AU 2947795A AU 29477/95 A AU29477/95 A AU 29477/95A AU 2947795 A AU2947795 A AU 2947795A AU 2947795 A AU2947795 A AU 2947795A
Authority
AU
Australia
Prior art keywords
biologically active
active agents
delivery systems
membrane permeability
controlling membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29477/95A
Inventor
Durairaj Bommi Bommannan
Tung-Fen Chen
Russell O Potts
Ooi Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cygnus Inc
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Publication of AU2947795A publication Critical patent/AU2947795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
AU29477/95A 1994-06-24 1995-06-23 Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability Abandoned AU2947795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26530694A 1994-06-24 1994-06-24
US265306 1994-06-24
PCT/US1995/007951 WO1996000111A1 (en) 1994-06-24 1995-06-23 Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability

Publications (1)

Publication Number Publication Date
AU2947795A true AU2947795A (en) 1996-01-19

Family

ID=23009917

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29477/95A Abandoned AU2947795A (en) 1994-06-24 1995-06-23 Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability

Country Status (5)

Country Link
EP (1) EP0766579A1 (en)
JP (1) JPH10511008A (en)
AU (1) AU2947795A (en)
CA (1) CA2194010A1 (en)
WO (1) WO1996000111A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6009345A (en) * 1992-08-17 1999-12-28 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
DK1314400T3 (en) * 1996-12-31 2007-10-15 Altea Therapeutics Corp Microporation of tissues for delivery of bioactive agents
DE69826124T3 (en) 1997-06-30 2007-10-11 Institut Gustave Roussy ADMINISTRATION OF NUCLEIC ACID IN CROSS-LINKED MUSCLES
KR20010020570A (en) 1997-06-30 2001-03-15 자끄 사비나 Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor
AU4335897A (en) * 1997-09-08 1999-03-29 Becton Dickinson & Company Iontophoretic delivery of buprenorphine
TW368420B (en) * 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
ATE220935T1 (en) * 1997-11-04 2002-08-15 Genetronics Inc COMBINED ELECTROPORATION AND IONTOPHORESIS DEVICE FOR DRUG AND GENE ADMINISTRATION
WO2003046171A1 (en) 2001-11-27 2003-06-05 Cellectricon Ab A method for combined sequential agent delivery and electroporation for cell structures and use thereof
US6778853B1 (en) 1997-12-17 2004-08-17 University Of South Florida Electroporation device
US6192270B1 (en) * 1998-08-14 2001-02-20 Genetronics, Inc. Apparatus and method for the delivery of drugs and genes into tissue
US6148232A (en) * 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
US6424862B1 (en) * 1999-02-10 2002-07-23 Gmp Drug Delivery, Inc. Iontophoresis electroporation and combination patches for local drug delivery to body tissues
ATE354376T1 (en) 1999-10-14 2007-03-15 Pola Chem Ind Inc COMPOSITIONS FOR ELECTROPORATION
JP4566496B2 (en) * 1999-12-15 2010-10-20 ユニヴァーシティ オブ サウス フロリダ Electroporation element and electroporation method
WO2004036202A1 (en) 2002-10-16 2004-04-29 Cellectricon Ab Nanoelectrodes and nanotips for recording transmembrane currents in a plurality of cells
US20040253249A1 (en) * 2003-04-02 2004-12-16 Rudnic Edward M. Pulsatile transdermally administered antigens and adjuvants
MXPA06005509A (en) * 2003-11-13 2007-05-23 Johnson & Johnson System and method for transdermal delivery.
ES2334681T3 (en) * 2004-03-19 2010-03-15 Mcneil Ab MEANS FOR THE TRANSDERMIC ADMINISTRATION OF NICOTINE.
CA2696227A1 (en) 2007-10-17 2009-04-23 Transpharma Medical Ltd. Dissolution rate verification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0615461B1 (en) * 1991-12-03 1996-09-25 Alza Corporation Iontophoretic delivery device and power supply therefor
JPH0670987A (en) * 1992-08-28 1994-03-15 Katsuro Tachibana Medicine dosing and body liquid taking-out unit and device therefor

Also Published As

Publication number Publication date
CA2194010A1 (en) 1996-01-04
EP0766579A1 (en) 1997-04-09
WO1996000111A1 (en) 1996-01-04
JPH10511008A (en) 1998-10-27

Similar Documents

Publication Publication Date Title
AU2947795A (en) Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability
AU1623099A (en) Rate controlling membranes for controlled drug delivery devices
AU3783395A (en) Drug-loaded elastic membrane and method for delivery
HK1068821A1 (en) Sustained delivery of an active agent using an implantable system
ZA986631B (en) Osmotic delivery system osmotic delivery system semipermeable body assembly and method for controlling delivery rate of beneficial agents from osmotic delivery systems
ZA986627B (en) Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents
AU6691496A (en) Enhanced artificial viral envelopes for cellular delivery of therapeutic substances
IL142807A0 (en) Controlled delivery of active agents
AU7796198A (en) Novel acoustically active drug delivery systems
AU2484399A (en) Controlled release delivery of peptide or protein
AU7482096A (en) Voice command and control medical care system
AU7736196A (en) Bactericidal permeability increasing protein (BPI) for treating conditions associated with corneal transplantation
EP1020982A4 (en) Boosting active filter system and controller for boosting active filter
AU4847896A (en) Production of biologically active recombinant bovine follicle stimulating hormone (rec bfsh) in the baculovirus expression system
AU1061699A (en) Use of biologically active glass as a drug delivery system
AU8166098A (en) Removal of biologically active agents
AU7840994A (en) Active substance delivery system
AU2999995A (en) Self-emulsifying drug delivery system
AU4183293A (en) Auditory prosthesis with user-controlled feedback cancellation
AU7092196A (en) Administration of biologically active material
AU6032598A (en) Pulsatile delivery of diltiazem hcl
EP0844850A4 (en) System for controlling the spread of hiv/aids and other infectious diseases
IL142502A0 (en) Intermediates for the preparation of biologically active benzothiazolone ethanamines
AU1948995A (en) Combinations of active insecticide substances
AU3958895A (en) Membrane expression of heterologous genes